RxDoctor Payments Data

Gerry Situ, PA

Physician Assistant · Albuquerque, NMNPI 1285227272

Payments from drug & device makers

$1,122in general payments, 2019–2025

Across 56 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Specialty L.p.$125
  • Pfizer$118
  • AstraZeneca$114
  • AbbVie$104
  • Astellas Pharma US Inc$103
  • Exact Sciences$94
  • plus $464 from 12 others

What the payments were for

  • Food & beverage$1,122100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,122 in reported general payments places this provider in the 80th percentile of 635 physician assistant providers in New Mexico.

See all physician assistant providers in New Mexico

Medicare billing

Part B allowed, 2024
$56,371
Medicare patients
160
Services billed
973

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$34,267
TrulicityDulaglutide13$21,224
RybelsusSemaglutide18$18,022
EliquisApixaban16$16,442
Spiriva RespimatTiotropium Bromide24$14,763
MounjaroTirzepatide11$12,329
SymbicortBudesonide/Formoterol Fumarate36$7,807
Fluticasone-SalmeterolFluticasone Propion/Salmeterol31$4,040
Advair HfaFluticasone Propion/Salmeterol12$3,665
Albuterol Sulfate HfaAlbuterol Sulfate93$2,368
Atorvastatin Calcium192$1,949
Tamsulosin Hcl110$1,690
Azelastine Hcl61$1,478
Levothyroxine Sodium121$1,242
Lisinopril155$1,237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$79$52,29040 claims
Lilly USA, LLCTrulicity, Mounjaro$93$33,55324 claims
PfizerEliquis$118$16,44216 claims
AstraZenecaSymbicort$114$7,80736 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 635 physician assistant providers in New Mexico.

Other physician assistant in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →